An initial, in-person comprehensive evaluation and customized weight loss plan Follow-up visits (in-person or virtual) at 1 month, 3 months, 6 months, and 9 months
A compliant 90471 encounter should include Dose administered Patient or guardian consent Provider signature or e-signature Injection site (left deltoid, right thigh, etc.) Route (IM, SQ, intradermal, or percutaneous) Observation period and any adverse reactions noted Vaccine name, manufacturer, lot number, and expiration date Vaccine Information Statement (VIS) provided to the patient (federal law requires VIS distribution for all CDC-covered vaccines) The ICD-10 code Z23 ( Encounter for immunization ) is the standard diagnosis pairing for routine preventive vaccines
However, Mounjaro is a completely different medication from Foundayo (orforglipron)different molecule, different mechanism (dual GIP/GLP-1 vs GLP-1 only), and different administration (injection vs pill)
The agency states that counterfeit drugs claim to be authentic, but they may contain harmful ingredients, too little active ingredient, too much, or no active ingredient at all
Week 4: Evaluate and adjust
Rather than stopping abruptly, many patients benefit from a planned transition to maintenance therapy or dose reduction
